D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 17 420 KRW -1.53% Market Closed
Market Cap: 787.9B KRW

Intrinsic Value

The intrinsic value of one Dongkook Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 17 420 KRW, Dongkook Pharmaceutical Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Dongkook Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Dongkook Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Dongkook Pharmaceutical Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Dongkook Pharmaceutical Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Dongkook Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Dongkook Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Dongkook Pharmaceutical Co Ltd.

Explain Valuation
Compare Dongkook Pharmaceutical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Dongkook Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dongkook Pharmaceutical Co Ltd

Current Assets 537B
Cash & Short-Term Investments 114B
Receivables 236.9B
Other Current Assets 186.1B
Non-Current Assets 461.4B
Long-Term Investments 114.2B
PP&E 294.6B
Intangibles 42.8B
Other Non-Current Assets 9.7B
Current Liabilities 239B
Accounts Payable 106.4B
Accrued Liabilities 7.9B
Short-Term Debt 30.1B
Other Current Liabilities 94.6B
Non-Current Liabilities 133.7B
Long-Term Debt 26.9B
Other Non-Current Liabilities 106.8B
Efficiency

Free Cash Flow Analysis
Dongkook Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Dongkook Pharmaceutical Co Ltd

Revenue
869B KRW
Cost of Revenue
-399.5B KRW
Gross Profit
469.5B KRW
Operating Expenses
-381.9B KRW
Operating Income
87.6B KRW
Other Expenses
-27.6B KRW
Net Income
60B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Dongkook Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Positive ROE
Healthy Operating Margin
hidden
Profitability
Score

Dongkook Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Dongkook Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Long-Term Solvency
High Altman Z-Score
hidden
Solvency
Score

Dongkook Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Dongkook Pharmaceutical Co Ltd

Wall Street analysts forecast Dongkook Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 25 500 KRW with a low forecast of 25 250 KRW and a high forecast of 26 250 KRW.

Lowest
Price Target
25 250 KRW
45% Upside
Average
Price Target
25 500 KRW
46% Upside
Highest
Price Target
26 250 KRW
51% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Dongkook Pharmaceutical Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Dongkook Pharmaceutical Co Ltd stock?

The intrinsic value of one Dongkook Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW.

Is Dongkook Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 17 420 KRW, Dongkook Pharmaceutical Co Ltd is hidden .

Back to Top